Search results
6 dni temu · In this study, we aimed to determine the maximum total daily insulin dose and the number of days required to reach the maximum insulin dose according to illness severity and factors associated with the need for maximum insulin dose in patients with COVID-19 who used insulin during hospitalization.
18 lip 2020 · Uncontrolled hyperglycaemia is associated with poor clinical outcomes among hospitalised patients with coronavirus disease 2019 (COVID-19). This review provides a practical guidance on the use of the basal-bolus insulin regimen for management of hyperglycaemia in hospitalised patients.
18 lip 2020 · Basal-bolus insulin therapy is a safe and effective intervention for the management of hyperglycaemia in hospitalised patients. The aim of this article is to provide a practical guidance for the use of the basal-bolus insulin regimen in hospitalised patients with COVID-19 and diabetes mellitus.
1 paź 2021 · Patients with Covid-19 place new challenges on the management of type 2 diabetes, including the questions of whether glucose-lowering therapy should be adjusted during infection and how to manage a return to normal care after resolution of Covid-19 symptoms.
9 lis 2021 · This promoted a review of patients positive for COVID-19 requiring ≥100 units/hour of continuous intravenous insulin infusion (CIVII) admitted to our institution, a 1368-bed comprehensive quaternary care mixed academic/community referral center between 1 March and 30 April 2020.
insulin concentrations. Based on this review, the purpose of this letter is to draw further attention to the need for further studies evaluating patients positive for COVID-19 requiring ≥100 units/hour of insulin and its impact on COVID-19 treatment outcomes. Contributors JT, MV, MN, and JL collected the data and wrote the manuscript.
11 sty 2022 · To evaluate the effect of the combination of linagliptin and insulin on metabolic control and prognosis in hospitalized patients with severe acute respiratory syndrome coronavirus 2...
